HTL BIOTECHNOLOGY

HTL Biotechnology is a French biotech company and world leader in the development and responsible bioproduction of pharmaceutical-grade biopolymers. These biopolymers are used by healthcare companies to develop treatments in a range of leading therapeutic areas such as ophthalmology, dermatology, medical aesthetics and rheumatology.

As a pioneer in the bioproduction of Hyaluronic Acid and DNA for over 30 years, HTL Biotechnology plays a leading role in innovation in the biopolymers sector, collaborating with research entities and biotech companies to meet tomorrow's medical needs in areas such as regenerative medicine and drug delivery.

As a fast-growing international company, HTL Biotechnology promotes French excellence and know-how in bio-production and future technologies on the international stage. Almost 80% of its production is exported to more than 30 countries. To meet the world's growing need for biopolymers, HTL Biotechnology has expanded its international presence by opening subsidiaries in Singapore and the United States, including the construction of a production unit.

Historically based in Javené (Brittany), the company brings together production, innovation, research and development and quality activities on the same site.

In total, HTL Biotechnology employs nearly 300 people worldwide.

FEEL THE DIFFERENCE WITH HTL INSIDE